Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eTheRNA
Biotech
Former Takeda exec takes reins at Tessa—Chutes & Ladders
Former Takeda exec takes reins at Tessa. Former bluebird regulatory chief jumps aboard Tessera. Aeglea CEO departs after facing regulatory pushback.
Gabrielle Masson
,
Max Bayer
Aug 26, 2022 9:30am
ETheRNA nabs €34M for mRNA vaccines—including COVID-19 candidate
Jun 15, 2020 11:00pm